Symptomatic Improvement in Irritable Bowel Syndrome With Oral Ketamine.

While dietary changes remain the gold standard for IBS, this patient experience highlights ketamine as a potential adjunct therapy.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-11-01
Citations
1
Primary Topic
Gastrointestinal motility and disorders
Type
article
Field-Weighted Citation Impact
0.46
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Symptomatic Improvement in Irritable Bowel Syndrome With Oral Ketamine.

Omar Dyara, Harvey J. Woehlck, Natasha Topoluk
1 citations
PubMed
Gastrointestinal motility and disorders
0.46
article

Symptomatic Improvement in Irritable Bowel Syndrome With Oral Ketamine.

Omar Dyara, Harvey J. Woehlck, Natasha Topoluk
article en
1 citations

Abstract

While dietary changes remain the gold standard for IBS, this patient experience highlights ketamine as a potential adjunct therapy.

PubMedVol. 123(5)
Medical College of Wisconsin (US)
Openalex Percentile: Top 31%
Gastrointestinal motility and disorders
0.46
OpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Symptomatic Improvement in Irritable Bowel Syndrome With Oral Ketamine. — Omar Dyara, Harvey J. Woehlck, et al. · PubMed (2024) | TGRS Research Map | TGRS